Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

85 results

Stibbe advises on the contemplated IPO of Agendia

Stibbe advises biotech company

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

Stibbe advises major pharmaceutical company

Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.

Stibbe advises on the IPO of Tornier

Stibbe advises Cellerix

Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.

The latest Legal Updates straight to your mailbox

We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.

De laatste Legal Updates direct in uw mailbox

Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.

Les dernières actualités juridiques directement dans votre boîte e-mail

Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates.

Legal Considerations for Artificial Intelligence in the Life Sciences Sector

This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.

The European Health Data Space (EHDS): new opportunities and obligations for healthcare institutions

The European Health Data Space (EHDS) will enter into force on 25 March 2025. The aim of the new European Regulation (EU) 2025/327 on the EHDS is to optimise the exchange of and access to health information within the EU.

Tom Barkhuysen

Partner Amsterdam

Tom Barkhuysen

Partner Amsterdam

Stibbe advises Aedifica

Stibbe has advised Aedifica on the further expansion of its healthcare real estate portfolio in the Netherlands with the acquisition and lease of 2 elderly care residences in Oss and Dordrecht.

Pagination

  • Previous page
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
Reset filters
Date
Content type
  • Article (22)
  • Event (2)
  • Inside Stibbe (1)
  • Matter (42)
  • Podcast (1)
  • People (17)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (437)
  • Capital Markets (251)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (884)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (148)
  • Employment, Benefits and Pensions (419)
  • Energy, Industry and Climate (320)
  • Environment and Planning (913)
  • ESG & Sustainability (307)
  • EU and Competition Law (486)
  • Financial Regulation (176)
  • Infrastructure and Mobility (205)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (147)
  • Litigation and Arbitration (435)
  • Mass Litigation (92)
  • Privacy and Data Protection (206)
  • Private Equity (200)
  • Procurement Law (128)
  • Public Law (1219)
  • Real Estate (487)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (454)
  • Tech (197)
  • Technology, Media and Telecommunications (339)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (23)
  • EU Law (14)
  • LU Law (7)
  • NL Law (44)
Language
  • Dutch (9)
  • English (74)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information